Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1Breast 1

Conditions

Breast Neoplasms 7Vulvar Neoplasms 1Vaginal Neoplasms 1Vaginal Atrophy 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Sexual Dysfunction, Physiological 1Metastatic Breastcancer 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Depression 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms, Male 1Atrophic Vaginitis 1Anxiety Disorders 1

Interventions

Paclitaxel 10pembrolizumab 9Cyclophosphamide 9Flow Cytometry 7sargramostim 6Therapeutics 6Taxes 5Polymerase Chain Reaction 5Immunoenzyme Techniques 5Docetaxel 5Carboplatin 5aldesleukin 4Psychiatric Rehabilitation 4Fulvestrant 4Filgrastim 4ribociclib 3Trastuzumab 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Nivolumab 3Mass Spectrometry 3Interleukin-12 Subunit p35 3Immunologic Techniques 3Immunohistochemistry 3Gene Expression Profiling 3Amplified Fragment Length Polymorphism Analysis 3Amifostine 3talazoparib 2spartalizumab 2sacituzumab govitecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ovarian Epithelial × Dehydroepiandrosterone × Breast × Clear all
NCT01376349 2019-02-07

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Alliance for Clinical Trials in Oncology

Phase 3 Completed
464 enrolled 8 charts
BreastGynecologicOther

Carcinoma, Ovarian Epithelial, Anxiety Disorders, Breast Neoplasms, Uterine Cervical Neoplasms, Depression, Fallopian Tube Neoplasms, Sexual Dysfunction, Physiological, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡